Novotech Pty Ltd. To Present Benefits Of Outsourcing Clinical Trials To Australia; CEO Invited To Speak At Inaugural Sachs Bloomberg CRO Partnering Forum, Boston
10/19/2005 5:13:00 PM
BOSTON--(BUSINESS WIRE)--March 14, 2005--Novotech, Australia's leading contract research organization (CRO), CEO Alek Safarian has been invited to present Australia's outstanding clinical trials capabilities at the inaugural Sachs Bloomberg CRO Partnering Forum in Boston (March 15, 2005).
In the past three years, Novotech has worked with more than 15 U.S.-based pharmaceutical and biotech companies, as well as many major European pharmas.
comments powered by